We are live on ! Find out more
BXC icon

BlueLinx

175 hedge funds and large institutions have $780M invested in BlueLinx in 2024 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 54 increasing their positions, 62 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

56% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 18

5% more funds holding

Funds holding: 167175 (+8)

2.48% more ownership

Funds ownership: 88.66%91.14% (+2.5%)

8% more call options, than puts

Call options by funds: $5.65M | Put options by funds: $5.22M

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

2% less capital invested

Capital invested by funds: $797M → $780M (-$16.7M)

13% less repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 62

Holders
175
Holders Change
+8
Holders Change %
+4.79%
% of All Funds
2.31%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
28
Increased
54
Reduced
62
Closed
18
Calls
$5.65M
Puts
$5.22M
Net Calls
+$428K
Net Calls Change
+$2.56M
Name Holding Trade Value Shares
Change
Change in
Stake
MIM
26
Meros Investment Management
Texas
$5.91M -$340K -2,963 -5%
Lord, Abbett & Co
27
Lord, Abbett & Co
New Jersey
$5.86M -$59.7K -521 -0.9%
Barclays
28
Barclays
United Kingdom
$5.74M +$1.25M +10,940 +24%
Morgan Stanley
29
Morgan Stanley
New York
$5.61M -$1.42M -12,348 -18%
Qube Research & Technologies (QRT)
30
Qube Research & Technologies (QRT)
United Kingdom
$5.52M +$1.44M +12,586 +30%
DLP
31
De Lisle Partners
United Kingdom
$5.19M +$286K +2,500 +5%
UBS Group
32
UBS Group
Switzerland
$5.16M +$5.06M +44,147 +690%
EF
33
Empowered Funds
Pennsylvania
$4.83M -$2.31M -20,156 -30%
Two Sigma Advisers
34
Two Sigma Advisers
New York
$4.32M -$665K -5,800 -12%
Bank of America
35
Bank of America
North Carolina
$4.04M +$712K +6,209 +19%
AQR Capital Management
36
AQR Capital Management
Connecticut
$3.96M -$1.59M -13,864 -26%
Two Sigma Investments
37
Two Sigma Investments
New York
$3.93M -$1.41M -12,302 -24%
Deutsche Bank
38
Deutsche Bank
Germany
$3.89M +$277K +2,416 +7%
AllianceBernstein
39
AllianceBernstein
Tennessee
$3.74M -$384K -3,350 -8%
AG
40
Algert Global
California
$3.66M -$720K -6,282 -15%
Bank of New York Mellon
41
Bank of New York Mellon
New York
$3.6M -$524K -4,572 -11%
PCM
42
Portolan Capital Management
Massachusetts
$3.58M +$3.55M +31,006 +765%
GLA
43
Great Lakes Advisors
Illinois
$3.58M -$188K -1,643 -4%
Raymond James Financial
44
Raymond James Financial
Florida
$3.45M +$3.87M +33,780 New
OLA
45
Oliver Luxxe Assets
New Jersey
$3.15M +$1.78M +15,515 +105%
GC
46
Globeflex Capital
California
$3.12M
N
47
Nuveen
North Carolina
$2.82M -$64.6K -564 -2%
Massachusetts Financial Services
48
Massachusetts Financial Services
Massachusetts
$2.76M -$92.4K -806 -3%
BGIM
49
Brandywine Global Investment Management
Pennsylvania
$2.74M -$161K -1,404 -5%
T. Rowe Price Associates
50
T. Rowe Price Associates
Maryland
$2.72M +$520K +4,539 +21%

BXC Hedge Fund Activity: Q4 2024 in Review

175 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in BlueLinx (BXC) for Q4 2024, worth a combined $780M — down 2.1% from $797M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new BXC positions and 18 closed out — a net gain of 10 holders — while 54 added to existing stakes and 62 trimmed.

The largest buyer was River Road Asset Management, opening a new position worth an estimated $8.46M. The largest seller was Voss Capital, cutting an estimated $9.47M.

  • 175 institutional investors held BlueLinx (BXC) as of Q4 2024, up from 167 in Q3 2024.
  • Funds reported $780M of BlueLinx stock for Q4 2024, down 2.1% quarter-over-quarter.
  • 28 funds opened new BlueLinx positions in Q4 2024 and 18 closed out, a net change of +10 holders.
  • The largest BlueLinx buyer in Q4 2024 was River Road Asset Management, an estimated $8.46M added.
  • The largest BlueLinx seller in Q4 2024 was Voss Capital, an estimated $9.47M sold.

Based on aggregated 13F filings for Q4 2024.